Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- University Hospitals Cleveland Medical Center
- Study ID
- NCT03829787
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Eye tracking — DEVICESubjects will be assessed for attentional biases, reward sensitivity, and cognitive control using eye tracking technology
Study Details
The purpose of this study is to use eye-tracking technology to study attentional biases, reward sensitivity, and cognitive control in adult patients with bipolar disorder with or without anxiety and/or substance use disorder comorbidity.
Key Dates
- Start date
- Mar 27, 2019
- Status verified
- Oct 2025
- Primary completion
- Sep 1, 2026
- Completion
- Sep 1, 2026
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Bipolar without Anxiety or Substance Use DisorderSubjects who are diagnosed with bipolar disorder but do not have any current anxiety or substance use disorders
- Arm: Bipolar disorder with a current anxiety disorder onlySubjects who are diagnosed with bipolar disorder and a current anxiety disorder (generalized anxiety disorder, panic disorder, and/or social phobia) but not a current substance use disorders
- Arm: Bipolar disorder with a current anxiety disorder and a currentSubjects who are diagnosed with bipolar disorder and a current anxiety disorder (generalized anxiety disorder, panic disorder, and/or social phobia) AND a current substance use disorders
- Arm: Bipolar disorder with a current substance use disorder onlySubjects who are diagnosed with bipolar disorder \& a substance use disorders but not a current anxiety disorder
- Arm: Healthy Volunteers
Primary Outcome Measure
Measure the differences in attentional bias among the 5 groups by assessing how long it takes a subject to locate and fixate on each face on the screen [ Time Frame: Baseline ]
Central Contacts
- Nicole Jones216/844-2862
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Hospitals Cleveland Medical Center - Mood Disorders Program | Cleveland | Ohio | 44106 | Keming Gao, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Cleveland, OH
By condition
By specialty
Related Studies
- Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderPHASE3 · Recruiting · Intra-Cellular Therapies, Inc. · Phoenix, Arizona
- A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) InhibitorPHASE4 · Recruiting · Neurocrine Biosciences · Bryant, Arkansas
- Evaluation of Patients With Mood and Anxiety Disorders and Healthy VolunteersRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- Psychiatric Genotype/Phenotype Project RepositoryEnrolling By Invitation · Vanderbilt University · Nashville, Tennessee